Examining the Architecture of Next-Gen Biotherapeutic Modalities

Join the discussion on how the biopharmaceutical industry is revolutionizing the design, durability, and global scalability of new biotherapeutic modalities through innovations in molecule design and next-generation delivery platforms.

Register Free: https://www.biopharminternational.com/bp_w/Modalities

Event Overview:

This episode of BioPharm Drug Digest will examine the technical shift in development pipelines toward multifunctional biotherapeutic modalities. The episode will dive into innovations in the design of new modalities for antibodies, RNA therapy, and cell therapy, such as the use of programmable biology and next-generation delivery platforms. By leveraging accelerated regulatory pathways and precision-driven discovery, the biopharmaceutical industry is effectively reshaping the design, durability, and global scalability of the next generation of biotherapeutics.

Key Learning Objectives:

• Insight into designing multifunctional antibody therapies
• How new approaches like programmable biology impact precision
• Optimization of next-generation drug delivery systems
• How innovative approaches like digitized biology models can scale therapy development

Who Should Attend:

• R&D and biotherapeutic design scientists
• process development and manufacturing engineers
• regulatory affairs and clinical development specialists
• digital transformation and data scientists
  

Speaker:

More information coming soon!

Register Free: https://www.biopharminternational.com/bp_w/Modalities